PCSK9 and fragile X syndrome: Interestingly, no associations were observed between plasma level of the proprotein convertase subtilisin/kexin type 9 (PCSK9) and total/LDL cholesterol in FXS patients, despite the existence of a clear correlation in control individuals [163].